logo

Alexion Pharmaceuticals Inc. (ALXN)



Trade ALXN now with
  Date
  Headline
6/11/2021 3:05:15 AM Caelum Biosciences And Alexion Announce New Phase 2 Safety And Tolerability Data For CAEL-101
5/25/2021 2:23:44 AM UK CMA To Assess AstraZeneca-Alexion Deal; Invites Comments On Transaction
5/11/2021 9:31:31 AM Alexion Shareholders Approve Acquisition By AstraZeneca; Deal Expected To Close In Q3
4/30/2021 8:04:53 AM Alexion Pharma Q1 GAAP EPS $2.86; Non-GAAP EPS $3.52
4/16/2021 8:37:36 AM AstraZeneca Receives US Clearance Of Proposed Acquisition Of Alexion
2/4/2021 8:08:59 AM Alexion Q4 Total Revenues $1.59 Bln, 15% Increase From Last Year
11/20/2020 2:24:49 AM Alexion: EC Approves New 100 Mg/mL Intravenous Formulation Of ULTOMIRIS Or Ravulizumab